Institutional shares held 117 Million
225K calls
743K puts
Total value of holdings $3.79B
$7.29M calls
$24M puts
Market Cap $4.79B
148,138,000 Shares Out.
Institutional ownership 79.02%
# of Institutions 405


Latest Institutional Activity in BRKR

Top Purchases

Q2 2025
Orbis Allan Gray LTD Shares Held: 4.68M ($151M)
Q2 2025
Aqr Capital Management LLC Shares Held: 3.33M ($108M)
Q2 2025
Edmond De Rothschild Holding S.A. Shares Held: 1.51M ($48.7M)
Q2 2025
Citadel Advisors LLC Shares Held: 2.71M ($87.8M)
Q2 2025
Norges Bank Shares Held: 1.08M ($34.9M)

Top Sells

Q2 2025
Alliancebernstein L.P. Shares Held: 141K ($4.56M)
Q2 2025
T. Rowe Price Investment Management, Inc. Shares Held: 11.4M ($370M)
Q2 2025
Bank Of America Corp Shares Held: 933K ($30.2M)
Q2 2025
Fil LTD Shares Held: 1.7M ($55M)
Q2 2025
Two Sigma Investments, LP Shares Held: 512K ($16.6M)

About BRKR

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.


Insider Transactions at BRKR

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
192K Shares
From 15 Insiders
Grant, award, or other acquisition 33.9K shares
Open market or private purchase 123K shares
Exercise of conversion of derivative security 35K shares
Sell / Disposition
29.6K Shares
From 4 Insiders
Payment of exercise price or tax liability 26.3K shares
Open market or private sale 3.35K shares

Track Institutional and Insider Activities on BRKR

Follow BRUKER CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BRKR shares.

Notify only if

Insider Trading

Get notified when an Bruker Corp insider buys or sells BRKR shares.

Notify only if

News

Receive news related to BRUKER CORP

Track Activities on BRKR